Sequential Expression of C-fos Protooncogene, TNF-alpha, and Dynorphin Genes in Spinal Cord Following Experimental Traumatic Injury
Overview
Molecular Biology
Neurology
Pathology
Authors
Affiliations
Reverse transcription-polymerase chain reaction (RT-PCR) was used to estimate dynamic changes in levels of c-fos protooncogene, tumor necrosis factor alpha (TNF-alpha), and preprodynorphin messenger ribonucleic acid (mRNA) isolated from individual segments (T1 to T12) of rat spinal cord following graded impact trauma (50 or 100 g/cm) to the T9 segment of pentobarbital-anesthetized rats. Trauma caused elevation of c-fos mRNA at the trauma site by 30 min after injury that was related to injury severity. At this time, increased levels of TNF-alpha (but not of preprodynorphin) mRNA were also found. By 24 h, c-fos and TNF-alpha mRNA had returned to normal levels at trauma site, but were now increased at more distal segments (T5 and T12). At 4 h after trauma, induction of preprodynorphin mRNA was detected at the trauma site; levels continued to be elevated at 24 h when they were also detected at T5 and T12. Increases for each mRNA were greater for severe as compared to moderate trauma. The injury dose- and time-dependent changes in c-fos, TNF-alpha, and preprodynorphin gene expression suggest that their respective proteins are synthesized in response to trauma, and may play a part in the secondary injury response. Later accumulation of message distant from the trauma site may reflect a progression of delayed damage along the spinal cord.
The Role of Tumor Necrosis Factor Following Spinal Cord Injury: A Systematic Review.
Lund M, Clausen B, Brambilla R, Lambertsen K Cell Mol Neurobiol. 2022; 43(3):925-950.
PMID: 35604578 PMC: 11414445. DOI: 10.1007/s10571-022-01229-0.
Martin K, Parvin S, Garraway S J Neurotrauma. 2018; 36(12):2000-2010.
PMID: 30520675 PMC: 6599394. DOI: 10.1089/neu.2018.5953.
Hormonal therapy in traumatic spinal cord injury.
Ludwig P, Patil A, Chamczuk A, Agrawal D Am J Transl Res. 2017; 9(9):3881-3895.
PMID: 28979667 PMC: 5622236.
Gu S, Xie R, Liu X, Shou J, Gu W, Che X Int J Mol Sci. 2017; 18(4.
PMID: 28368292 PMC: 5412318. DOI: 10.3390/ijms18040732.
Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases.
Liu Y, Shields L, Gao Z, Wang Y, Zhang Y, Chu T Mol Neurobiol. 2016; 54(7):5563-5572.
PMID: 27613281 DOI: 10.1007/s12035-016-0062-5.